AbbVie, Inc. (ABBV)
AbbVie Market Cap : 368.38B for March 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 189.47B |
| Biogen, Inc. | 26.76B |
| Gilead Sciences, Inc. | 175.40B |
| Johnson & Johnson | 571.82B |
| Eli Lilly & Co. | 819.81B |
Market Cap Related Metrics
| PE Ratio | 88.23 |
| PS Ratio | 6.037 |
| Price to Free Cash Flow | 20.72 |
| Price | 208.34 |
| Earnings Yield | 1.13% |
| Operating PE Ratio | 18.40 |
| Normalized PE Ratio | 29.65 |